Asepha Secures $4 Million Seed Funding to Revolutionize Pharmacy Operations with AI

Asepha, a pioneering startup in the application of artificial intelligence within pharmacy operations, has announced the closure of a $4 million seed funding round. This investment, led by Glasswing Ventures and Core Innovation Capital, with additional support from Panache, RedBud, MGV, Ripple Ventures, and Front Row Ventures, is poised to propel Asepha's innovative solutions to the forefront of the pharmacy industry. The funding underscores the critical need for technological advancements in addressing the widespread issue of pharmacy understaffing and the disproportionate amount of time pharmacists dedicate to administrative tasks.

The startup's AI-driven tools, including an OCR prescription entry agent with a 96% accuracy rate in processing handwritten prescriptions, a call agent capable of automating up to 70% of inbound calls, and a browser navigation agent for streamlining administrative duties, represent a significant leap forward in pharmacy operations. These technologies not only enhance operational efficiency but also improve accuracy, as demonstrated by a double-blinded trial where pharmacists preferred Asepha's AI responses over human responses 71% of the time.

With the newly acquired funds, Asepha plans to expand its engineering and go-to-market teams, establish a new office in New York City to strengthen its U.S. presence, and develop global partnerships. The company's success in attracting major Fortune 50 enterprise customers highlights the growing demand for its solutions. Eunice Wu, CEO and Co-Founder of Asepha, emphasized the transformative potential of freeing pharmacists from manual tasks to focus more on patient care, while CTO Can Uncu pointed to the responsible use of AI in redefining industry workflows.

Investors Rudina Seseri of Glasswing Ventures and Edwin Loredo of Core Innovation Capital have expressed strong support for Asepha's mission, citing its alignment with broader trends in pharmacy labor and its potential to significantly improve healthcare access and efficiency for patients worldwide. For more information on Asepha's innovative solutions, visit https://www.asepha.com.